Patents expiring in 2026

US 7084154

2-(aminomethyl) arylamide analgesics

Pharmacopeia Drug Discovery, Inc. · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084271

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pharmacopeia Drug Discovery, Inc. · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7083970

Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs

The Regents of the University of California · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084266

Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084239

Cancer peptides of NY-ESO-1/CAG-3

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084151

5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084149

Naphthalene derivatives, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084127

C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses

CAN-FITE BIOPHARMA LTD. · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7084132

Artemisinins with improved stability and bioavailability for therapeutic drug development and application

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087642

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087582

Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087392

Antiproliferative SgK reagents and methods

The Regents of the University of California · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087633

Method for treating perinatal asphyxia in a human or animal neonate

Universitair Medisch Centrum · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087723

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087715

Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses

Northwest Biotherapeutics, Inc. · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087648

Methods for modulating macrophage proliferation using polyamine analogs

The Regents of the University of California · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087603

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087597

Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087593

Benzimidazolidinone derivatives as muscarinic agents

ACADIA Pharmaceuticals Inc. · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087591

21-substituted progesterone derivatives as new antiprogestational agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087589

Methanocarba cycloakyl nucleoside analogues

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087413

Hyaluronan synthase gene and uses thereof

The Board of Regents of the University of Oklahoma · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7086862

Tooth bleaching process

DISCUS DENTAL, LLC · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087411

Fusion protein capable of binding VEGF

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087095

Hair coloring composition and method

HairMarker LLC · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7091343

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7090869

Method for producing preparation containing bioactive substance

Takeda Pharmaceutical Company Limited · Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7090864

Non-invasive gene targeting to ocular cells

The Regents of the University of California · Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7091247

Biphenyl compound

Takeda Pharmaceutical Company Limited · Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7090852

Venezuelan equine encephalitis virus replicon encoding marburg virus proteins

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 15 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094413

Combined therapy for treatment of HIV infection

The Regents of the University of California · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094598

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094045

Microencapsulation system and method

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094883

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094772

Phosphonate compounds

The Regents of the University of California · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094873

Polypeptide that interacts with heat shock proteins

The Board of Regents of the University of Texas System · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094406

Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services and Genelabs Technologies, Inc. · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094758

Apoptotic compounds

The Board of Regents of the University of Texas System · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094597

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

The Regents of the University of California · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094424

Cationic lipid compositions targeting angiogenic endothelial cells

The Regents of the University of California · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094404

Method for treating malignancy and autoimmune disorders in humans using tac antibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094411

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7094405

Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7097856

Dendrimeric support or carrier macromolecule

The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7097835

Immunoselective targeting agents and methods of use thereof

The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7098306

Method and compositions for treating hepatocellular cancer

The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)